Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/39745
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pawlitzki, Marc | - |
dc.contributor.author | Butryn, Michaela | - |
dc.contributor.author | Kirchner, Florian | - |
dc.contributor.author | Färber, Jacqueline | - |
dc.contributor.author | Beuing, Oliver | - |
dc.contributor.author | Minnerup, Jens | - |
dc.contributor.author | Meuth, Sven | - |
dc.contributor.author | Neumann, Jens | - |
dc.date.accessioned | 2021-11-29T10:45:29Z | - |
dc.date.available | 2021-11-29T10:45:29Z | - |
dc.date.issued | 2019 | - |
dc.date.submitted | 2019 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/41700 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/39745 | - |
dc.description.abstract | The rarity of primary angiitis of the central nervous system (PACNS) demands diagnostic and prognostic biomarkers. We retrospectively measured Neurofilament light chain (NFL) concentrations in cerebrospinal fluid in a severely relapsing PACNS patient at multiple time points during the course of the disease. A marked increase in NFL levels preceding the onset of neuro-axonal damage and arterial-vessel abnormalities was observed with magnetic resonance imaging as well as with MR- and conventional angiography. Thus, marked elevation of NFL in PACNS seems to occur ahead of definitive radiological abnormalities and might serve as a diagnostic biomarker. | eng |
dc.language.iso | eng | - |
dc.relation.ispartof | https://onlinelibrary.wiley.com/journal/23289503 | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.subject | Primary angiitis of the central nervous system (PACNS) | eng |
dc.subject | Biomarker | eng |
dc.subject | Neurofilament light chain (NFL) | eng |
dc.subject.ddc | 610.72 | - |
dc.title | CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis | eng |
dc.type | Article | - |
dc.identifier.urn | urn:nbn:de:gbv:ma9:1-1981185920-417004 | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | Annals of Clinical and Translational Neurology | - |
local.bibliographicCitation.volume | 6 | - |
local.bibliographicCitation.issue | 6 | - |
local.bibliographicCitation.pagestart | 1134 | - |
local.bibliographicCitation.pageend | 1137 | - |
local.bibliographicCitation.publishername | Wiley | - |
local.bibliographicCitation.publisherplace | Chichester [u.a.] | - |
local.bibliographicCitation.doi | 10.1002/acn3.790 | - |
local.openaccess | true | - |
dc.identifier.ppn | 167888460X | - |
local.bibliographicCitation.year | 2019 | - |
cbs.sru.importDate | 2021-11-29T10:39:02Z | - |
local.bibliographicCitation | Enthalten in Annals of Clinical and Translational Neurology - Chichester [u.a.] : Wiley, 2013 | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Medizinische Fakultät (OA) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Pawlitzki et al._CSF_2019.pdf | Zweitveröffentlichung | 1.45 MB | Adobe PDF | View/Open |